| Product Name | Multi-Tumor Marker (12-Item) Quantitative Assay Reagent, Fluorescence Flow Cytometry |
| Catalog No. | TMTR-HMM-0036 |
| Description | Twelve combined tests, covering the top 7 malignant tumors, assist in clinical diagnosis Lung cancer: Cyfra21-1, NSE, CEA, CA125, SCCA Liver cancer: AFP, CEA, free-b-hCG, CA199, CA242 Gastric cancer: CEA, free-b-hCG, CA199, CA242, AFP(CEA is commonly used for prognosis assessment and postoperative detection of gastric cancer) Esophageal cancer: CEA, Cyfra21-1, SCCA (Cyfra21-1 has a higher positive rate in esophageal cancer, and SCCA has a good detection rate for esophageal squamous cell carcinoma) Pancreatic cancer: CEA, CA199, CA242 (CA199 is the currently widely used classic indicator for pancreatic cancer) Prostate cancer: t-PSA, F-PSA (PSA is currently recognized as an indicator with high organ specificity. The ratio of f-PSA/T-PSA can avoid the gray zone of t-PSA detection and further improve accuracy.) Breast cancer: CEA, CA153, Cyfra21-1(CA153 is currently a better indicator for breast cancer, and the sensitivity of Cyfra21-1 can rival that of CA153) |
| Application | This product is used to assist in the diagnosis of liver cancer, various digestive tract tumors, ovarian cancer, breast cancer, pancreatic cancer, choriocarcinoma and lung cancer. |
| Test Item | AFP, CEA, NSE, CYFRA21-1, CA125, CA242, free-β-hCG, CA19-9, SCCA, T-PSA, F-PSA, CA15-3 |
| Specimen Type | Serum |
| Sample Capacity | 20-100 µL |
| Applicable Instruments | Multifunctional flow dot matrix analyzer, fully automatic flow fluorescence luminescence immunoanalyzer |
| Detection Method | Fluorescence Flow Cytometry |
| Storage | 2-8°C |
| Shelf Life | 12 months |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
